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Aims Although cardiac hybrid imaging, fusing single-photon emission computed tomography (SPECT) myocardial perfusion
imaging with coronary computed tomography angiography (CCTA), provides important complementary diagnostic
information for coronary artery disease (CAD) assessment, no prognostic data exist on the predictive value of
cardiac hybrid imaging. Hence, the aim of this study was to assess the prognostic value of hybrid SPECT/CCTA
images.
Methods
and results
Of 335 consecutive patients undergoing a 1-day stress/rest 99mTc-tetrofosmin SPECT and a CCTA, acquired on
stand-alone scanners and fused to obtain cardiac hybrid images, follow-up was obtained in 324 patients (97%). Sur-
vival free of all-cause death or non-fatal myocardial infarction (MI) and free of major adverse cardiac events (MACE:
death, MI, unstable angina requiring hospitalization, coronary revascularizations) was determined using the Kaplan–
Meier method for the following groups: (i) stenosis by CCTA and matching reversible SPECT defect; (ii) unmatched
CCTA and SPECT finding; and (iii) normal finding by CCTA and SPECT. Cox’s proportional hazard regression was
used to identify independent predictors for cardiac events. At a median follow-up of 2.8 years (25th–75th percentile:
1.9–3.6), 69 MACE occurred in 47 patients, including 20 death/MI. A corresponding matched hybrid image finding
was associated with a significantly higher death/MI incidence (P, 0.005) and proved to be an independent predictor
for MACE. The annual death/MI rate was 6.0, 2.8, and 1.3% for patients with matched, unmatched, and normal
findings.
Conclusion Cardiac hybrid imaging allows risk stratification in patients with known or suspected CAD. A matched defect on
hybrid image is a strong predictor of MACE.
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Introduction
The definition of functional relevance of a given coronary ste-
nosis by purely morpho-anatomical criteria has remained
controversial, despite many technical advances in invasive
angiography over the past decades. A coronary stenosis
.50% is generally perceived to confer haemodynamic
relevance, although many parameters which cannot be fully
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elucidated by documenting coronary luminology alone may
determine whether a given lesion may eventually cause
stress-induced ischaemia or not. Therefore, according to
evidence-based guidelines, the proof of ischaemia is essential
for best clinical practice prior to any revascularization pro-
cedure.1 Although in the recent prospective randomized
FAME trial,2 the superiority of the evidence-based approach
has been once more impressively documented; in many
instances, a more angiography-based approach has remained
standard in daily clinical practice. As revascularization of a
non-flow-limiting stenosis is not of benefit to the patient in
terms of prognostic or symptomatic improvement,2 single-
photon emission computed tomography (SPECT)-myocardial
perfusion imaging (MPI) has been suggested as a gatekeeper
for invasive coronary examinations.3 The recent introduction
of cardiac hybrid imaging integrating morphological information
obtained from non-invasive coronary computed tomography
angiography (CCTA) with the functional information from the
nuclear MPI now allows a comprehensive non-invasive assess-
ment of coronary artery disease (CAD). This can be equally
obtained from hybrid scanners4 or from software fusion of
CCTA and SPECT images separately acquired on stand-alone
scanners.5 The initial experience on the added clinical value
of hybrid imaging has provided encouraging results4,6 and has
been confirmed by several subsequent reports.7 In fact, these
studies support that hybrid images offer superior diagnostic
information with regard to the identification of the culprit
vessel and may potentially allow an improved risk stratification.
There are, however, no outcome data available so far. There-
fore, the aim of the present study was to assess the prognostic
predictive value of cardiac hybrid imaging.
Methods
Patient population and follow-up
We enrolled 335 consecutive patients who were referred for the
evaluation of known or suspected CAD by SPECT and CCTA and
therefore underwent a 1-day adenosine stress/rest 99mTc-tetrofosmin
SPECT and a CCTA 2+10 days apart from each other. The CCTA
and SPECT-MPI images were then fused to obtain cardiac hybrid
images. Follow-up was obtained with the following endpoints: all-cause
death (as declared in the medical charts) and non-fatal myocardial
infarction (MI) as defined by Thygesen et al.8 In addition, following
major adverse cardiac events (MACE) were included as combined end-
points: death, MI, unstable angina requiring hospitalization, and coron-
ary revascularization. The first event in each patient was used for the
survival analysis. All patients with revascularizations within the first 30
days were excluded because during this period revascularization could
potentially be directly triggered by the MPI or by the CCTA test result,
which would introduce a confounder between the diagnostic and the
prognostic value. The study protocol was approved by the institutional
review board (local Ethics Committee) and written informed consent
was obtained from each patient before enrolment. The pre-test likeli-
hood of CAD was determined using the Diamond and Forrester9
method, with a risk threshold of ,13.4% for low risk, between 13.4
and 87.2% for intermediate risk, and .87.2% for high risk, as reported
previously.
Single-photon emission computed
tomography-myocardial perfusion imaging
All patients underwent a 1-day electrocardiography (ECG)-gated stress/
rest protocol. Pharmacological stress was induced by infusion of adeno-
sine at a standard rate of 140 mg/kg/min and a dose of 300–350 MBq
99mTc-tetrofosmin was injected 3 min into the pharmacological stress.
After a delay of 45–60 min, the ECG-gated stress images were acquired.
Then, a three-fold higher dose 99mTc-tetrofosmin was administered
followed by a delay of 45–60 min before acquisition of the ECG-gated
rest data. The SPECT-MPI acquisition was performed on a dual-head
camera (Millenium VG and Hawkeye or Ventri, both GE Healthcare, Mil-
waukee, WI, USA) with a low-energy, high-resolution collimator, a 20%
symmetric window at 140 keV, and data were stored in a 64 × 64 matrix.
X-ray-based attenuation correction was performed as reported pre-
viously.10 Image analysis was performed using a commercially available
software package (Cedars QGS/QPS; Cedars-Sinai Medical Center,
Los Angeles, CA, USA). Reversible perfusion defects were identified as
reported previously.11 In brief, myocardial tomograms were divided
into 20 segments for each patient. Segments were scored by consensus
of two experienced readers using following five-point scoring system (0,
normal; 1, equivocal; 2, moderate; 3, severe reduction in radioisotope
uptake; and 4, absence of detectable tracer in a segment). A scan was
categorized as abnormal if two or more segments had stress scores
≥2. A reversible perfusion defect was defined as one in which a stress
defect was associated with a rest score ≤1 or a stress defect score of
4 with a rest score of 2. Only reversible defects were considered for
further analysis as ischaemia-driven patient management is most
evidence-based ascertaining best clinical practice.1,2 Radiation dose for
SPECT-MPI was calculated as 99mTc-tetrofosmin activity times
7.9 mSv/GBq.
Coronary computed tomography
angiography
All scans were performed on a 64-detector CT scanner (LightSpeed
VCT, GE Healthcare) with helical scanning (until 2007; n ¼ 241) or
prospective (from 2007; n ¼ 61) ECG-triggering as previously
described in detail.6,12,13 To achieve a target heart rate ,65 b.p.m.,
intravenous metoprolol (5–20 mg) was administered prior to the
CCTA examination if necessary. Furthermore, all patients received
2.5 mg sublingual isosorbiddinitrate 2 min prior to the scan.
The CCTA data sets were analysed using axial source images, multi-
planar reformations, and thin-slab maximum intensity projections on a
remote workstation (Advantage workstation 4.3, GE Healthcare). Cor-
onary lesions were visually assessed with regard to luminal stenosis. A
diameter stenosis ≥50% was considered clinically significant. Effective
radiation dose for CCTA was estimated as dose–length product times
a conversion coefficient for the chest k ¼ 0.014 mSv/(mGy cm).14
Image fusion
The image fusion of SPECT with CCTA was performed on a dedicated
workstation (Advantage Workstation 4.3, GE Healthcare) using the
CardIQ Fusion software package (GE Healthcare) as previously
described in detail5 (Figure 1). In brief, the fusion software provides
tools for the optimal alignment of axial source SPECT and CCTA
images and for SPECT image projection on the left ventricular (LV) epi-
cardial surface. The window presets for the colour scale projected on
the LV epicardium are adopted from the corresponding separate
SPECT images and remain unchanged during the fusion process. The
three-dimensional (3D) volume-rendered fusion images were dis-
played in different views including anterior, posterior, lateral, and
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apical views. The right ventricle could be faded away by a cardiac trans-
parency tool for better visualization of the septal wall.
Data interpretation
The fused SPECT and CCTA images were analysed by consensus of
two experienced nuclear cardiologists with regard to reversible per-
fusion defects and morphologically significant lesions (≥50%). A
matched hybrid imaging finding was defined as a reversible SPECT-MPI
defect in a territory subtended by a coronary artery with a significant
stenosis. All other combinations of pathological findings were classified
as unmatched. Thus, in order to assess the prognostic value of hybrid
imaging, all patients were assigned to one of the following three cat-
egories: (i) matched: CCTA and matched (reversible) SPECT findings
as defined above; (ii) unmatched: any unmatched pathological finding
from CCTA and/or SPECT; and (iii) normal: i.e. normal CCTA or
any luminal narrowing ,50% and no (fixed or reversible) defect by
SPECT. Figure 1 illustrates a patient with matched and a patient with
unmatched findings.
Statistical analysis
SPSS software (SPSS 15.0, SPSS Inc.) was used for statistical testing.
Quantitative variables were expressed as median and range and categ-
orical variables as frequencies or percentages. P-values for continuous
variables were calculated by one-way ANOVA. P-values for categorical
variables were calculated by the x2 test. Differences in event-free sur-
vival over time were analysed by the Kaplan–Meier method. The
log-rank test was used to compare the survival curves. Univariate
and multivariate Cox’s proportional hazard regression models were
used to identify independent predictors of cardiac events. Variables
were selected in a stepwise forward selection manner; entry and
retention sets with P, 0.05 were considered to indicate a significant
difference. Variables included in the models were age, male gender,
more than two risk factors (i.e. hypertension, hypercholesterolaemia,
smoking, diabetes mellitus, and a positive family history for CAD),
abnormal perfusion, stenosis ≥50%, and a matched hybrid finding. A
variable’s risk was expressed as hazard ratio with corresponding 95%
confidence interval. P-values from two-sided tests of ,0.05 were con-
sidered statistically significant.
Results
Patient characteristics
Single-photon emission computed tomography and CCTA were
performed in 335 patients. Follow-up was successful in 324 patients
(97%). Of these, 22 patients were excluded due to early revascular-
ization (,30 days). Baseline characteristics of the remaining 302
patients included in the final analysis are given in Table 1.
Single-photon emission computed
tomography and coronary computed
tomography angiography findings
Single-photon emission computed tomography revealed normal
perfusion in 244 patients (81%). An abnormal perfusion was
found in 58 patients (19%), of which 40 patients (13%) had a par-
tially (n ¼ 6) or fully (n ¼ 34) reversible defect. A normal CCTA
examination (i.e. no coronary wall changes or non-stenotic coron-
ary plaques) was observed in 198 patients (66%). Coronary com-
puted tomography angiography identified a significant stenosis in
104 patients (34%). Matched pathological hybrid findings (signifi-
cant CCTA stenosis with a reversible MPI defect) were observed
in 37 patients (12%). Unmatched findings were present in 69
patients (22%), whereas the remaining patients were normal by
both imaging methods (n ¼ 196, 67%). Among the 69 patients
with unmatched findings, the abnormal finding was confined to
SPECT in 2 (reversible defects) and to CT in 66 patients (including
18 patients with fixed defects in SPECT), whereas a pathological
finding was found in both SPECT (reversible defects) and CCTA
but in non-corresponding territories in 1 patient.
The estimated radiation dose for the CCTA was 15.0+4.9 mSv
when helical scanning was used (n ¼ 241). After introducing pro-
spective triggering for CCTA, the effective radiation dose was
1.8+ 0.6 mSv (n ¼ 61). The respective value for stress/rest
SPECT-MPI was 10.3+1.8 mSv.
Figure 1 Visualization of matched and unmatched cardiac hybrid images. Cardiac hybrid single-photon emission computed tomography/cor-
onary computed tomography angiography images of a 40-year-old patient show a stenosis [(A), arrow] and a matched anterolateral reversible
perfusion defect [arrowhead; stress (B)/rest (C)], whereas the hybrid image of a 59-year-old patient shows an unmatched finding, i.e. stenosis in
coronary computed tomography angiography [(D), arrow] but no findings in the hybrid image (E).
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Outcome data
During a median follow-up of 2.8 years (25th–75th percentile:
1.9–3.6 years), 69 MACE occurred in 47 patients (16%), including
12 all-cause deaths and 8 non-fatal MIs. In the matched group, 21
MACE occurred; of which, for 5 MACE, no information was avail-
able on whether the event occurred in the target vessel with the
matched finding or not (4 deaths without autopsy and 1 hospital-
ization for angina pectoris without coronary angiography). For the
remaining 16 MACE, we could (angiographically) assign 13 to the
index vessel identified by hybrid images, whereas in 3 patients
with angiographic total occlusion, the neighbouring artery was
revascularized, as origin of collaterals serving the target territory.
A total of 42 invasive coronary angiograms were performed
during follow-up.
According to the Kaplan–Meier curves, the most favourable
event-free survival was found in the normal followed by the
unmatched group, whereas the matched group had the most
unfavourable outcome with regard to death and non-fatal MI
(P, 0.005; Figure 2A) and combined MACE (P, 0.001;
Figure 2B). The predictive value of matched SPECT/CCTA findings
proved to be significant by Cox’s regression analysis (P, 0.001;
Table 2). In addition, by multivariate analysis, the presence of a
matched finding was confirmed as an independent predictor of
combined MACE (P, 0.01), although this fell short of statistical
significance for death and non-fatal MI. When the matched findings
were expanded to include fixed defects, this turned to significance
(multivariate hazard ratio 5.44, P, 0.005), reflecting the fact that
infarct tissue contributes to a significant risk of future events,
although there is less certainty about the appropriateness of
target vessel revascularization of infarcted territories.
Finally, the overall annual rate of death or MI was 2.2%. First-
year rates of death or MI were 8.1, 5.8, and 1.0% for patients
with matched, unmatched, and normal findings, respectively,
whereas the first-year rates of MACE were 27.0, 11.7, and 2.1%
for the respective patient groups. Similarly, in patients with
matched hybrid findings, the annual rate of death or MI was
highest at 6.0%, whereas for patients with unmatched and
normal findings, the respective values were 2.8 and 1.3% (P,
0.005; Figure 3A). The respective values for annual rate of MACE
were 21.0, 7.8, and 2.2% (,0.001; Figure 3B).
Discussion
Our results demonstrate that cardiac hybrid imaging with fused
SPECT/CCTA allows improved risk stratification in patients with
known or suspected CAD as a matched finding on hybrid image
is a strong predictor of MACE. Although in the past years a
number of studies have reported on the added diagnostic value
of cardiac hybrid imaging,6,7,15 the present study is the first to
document the prognostic value of the concurrent fused assess-
ment of coronary morphology and myocardial perfusion. In fact,
the results of the present study reveal that patients with stenosis
in CCTA and a matched reversible perfusion defect in SPECT
are at highest risk for future cardiac events.
Recommendations for the interventional coronary catheteriza-
tion1 suggest for best clinical practice that the addition of coronary
physiological measurements should complement traditional angio-
graphic information because this is essential for evidence-based
accurate clinical decision-making as has been recently underlined
by the prospective randomized FAME trial.2 Combining MPI with
CCTA allows non-invasive comprehensive CAD assessment which
may contribute to avoid unnecessary invasive angiographies.3,6
Accordingly, hybrid imaging has shown to provide an added diagnos-
tic information for culprit lesion identification and for guiding target
vessel revascularization.6 The present data extend these findings,
documenting that hybrid images allow accurate risk stratification.
A wealth of data has been published on the diagnostic accuracy
and the prognostic value of MPI. In contrast, only limited data are
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Table 1 Baseline characteristics
All Normal Unmatched Matched P-value
n 302 196 69 37
Age (years) 61+11 60+11 64+9 66+10 ,0.001
Males, n (%) 202 (67) 115 (59) 60 (87) 27 (73) ,0.001
Risk factors, n (%)
Hypertension 171 (57) 111 (57) 38 (55) 22 (59) 0.910
Dyslipidaemia 136 (45) 74 (38) 40 (58) 22 (59) 0.003
Diabetes 43 (14) 21 (11) 15 (22) 7 (19) 0.054
Smoking 85 (28) 44 (22) 28 (41) 13 (35) 0.009
Positive family history 82 (27) 45 (23) 23 (33) 14 (38) 0.074
Obesity (BMI ≥ 30) 59 (20) 41 (21) 9 (13) 9 (24) 0.269
Pre-test likelihood of CAD, n (%)
Low 26 (9) 22 (11) 3 (4) 1 (3) 0.085
Intermediate 229 (76) 145 (74) 57 (83) 27 (73) 0.323
High 47 (15) 29 (15) 9 (13) 9 (24) 0.275
CAD, coronary artery disease; BMI, body mass index.
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available on the prognostic value of anatomic imaging with
CCTA16– 18 or on the combination of CT and SPECT.19 In patients
with overall risk comparable to our study population, annual rates
of death or MI between 4.320 and 5.1%21 have been reported for
MPI abnormalities and between 2.718 and 5.3%17 for significant
lesions in CCTA. The annual rate of death or MI for matched find-
ings in the present study (6.0%) lies above this range, suggesting the
superiority of hybrid imaging for risk stratification. This superiority
may at least in part be due to the fact that 3D hybrid imaging pro-
vides additional information about haemodynamic lesion relevance
and facilitates lesion interpretation by allowing exact allocation of
perfusion defects to its subtending coronary artery. This cannot
reliably be achieved by mental integration of the side-by-side
CCTA and SPECT-MPI scan results as recently reported,
because standard myocardial distribution territories correspond
in only 50–60% with the real anatomic coronary tree.6 Although
in a low pre-test-probability population, a CCTA alone may be
appropriate to rule out CAD, the identification of matched findings
by hybrid imaging in an intermediate-risk population such as in the
present study allows discriminating patients with substantial risk
exceeding considerably the margin set to define ‘high risk’ by the
ACC/AHA guidelines for stable angina at 3–5%.22 In order to
provide clinically meaningful information on haemodynamically rel-
evant lesions in the present study, only reversible SPECT-MPI find-
ings were considered as a matched finding because ischaemia in
territories subtended by stenotic coronaries constitutes an indi-
cation for revascularization, whereas scar tissue does not. Our
results support the clinical importance of functional lesion charac-
terization particularly for prognostically relevant target vessel
revascularization and confirm that also fixed defects confer a pre-
dictive value for adverse events.
In addition to its prognostic value, hybrid imaging on hybrid
devices or in dedicated imaging facilities with stand-alone scanners
may confer the advantage of increasing the probability that patients
are getting a comprehensive anatomic and functional non-invasive
assessment before being sent to invasive catheterization. This
could contribute to substantially increase the currently reported
low yield of elective diagnostic invasive coronary angiography23
and potentially facilitate evidence-based coronary interventions.2,3
Study limitations
We acknowledge the following limitations: first, all-cause mortality
was used although this is not a direct cardiac endpoint. However,
an important advantage of all-cause death is the fact that it is easily
ascertained, it is not affected by adjudication bias, and therefore
constitutes the most valid endpoint.24 Secondly, the patients
Figure 2 The Kaplan–Meier survival curves showing the prog-
nostic value of cardiac hybrid imaging. Cardiac hybrid findings
predict (A) all-cause death or non-fatal myocardial infarction
(MI) and (B) major adverse cardiac events (death, MI, unstable
angina requiring hospitalization, and coronary revascularization).
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Table 2 Predictors of events at univariate and multivariate analyses (n 5 302)
Predictors MACE Death or MI
Univariate HR
(95% CI)
P-value Multivariate HR
(95% CI)
P-value Univariate HR
(95% CI)
P-value
Age 1.04 (1.01–1.07) 0.005 NA NS 1.09 (1.03–1.14) 0.002
Male gender 1.29 (0.68–2.45) 0.433 NA NS 2.12 (0.60–7.44) 0.241
≥3 risk factors 2.62 (1.48–4.65) ,0.001 NA NS 3.74 (1.39–10.05) 0.009
Reversible perfusion defect 6.23 (3.51–11.08) ,0.001 NA NS 3.88 (1.41–10.68) 0.009
Stenosis ≥50% 6.56 (3.46–12.45) ,0.001 3.12 (1.56–6.23) ,0.001 4.83 (1.68–13.91) 0.006
Matched SPECT/CCTA finding 7.48 (4.21–13.29) ,0.001 3.80 (1.76–8.21) 0.002 4.49 (1.63–12.37) 0.005
MACE, major adverse cardiac events; MI, non-fatal myocardial infarction; HR, hazard ratio; CI, confidence interval; NA, not applicable.
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group with matched hybrid findings was relatively small. This is due
to the fact that the probability of early coronary revascularization
(defined as exclusion criteria) is much higher in patients with
matched findings. Hence, many of these patients with highest risk
were excluded from further outcome analysis which leads to an
underestimation of the risk assessment. Nevertheless, there was
good risk discrimination between the matched and the other
groups, further supporting our results. Thirdly, in the univariate
analysis, the presence of ischaemia was an independent predictor
of adverse outcome, although this fell short of statistical signifi-
cance for the multivariate analysis in contrast to the previous
studies. This is at least in part due to the fact that the present
study included into the multivariate analysis CCTA, hybrid, and
MPI imaging results, i.e. findings which are linked by interaction.
Fourthly, the additive radiation burden from combined SPECT
and CCTA is a limitation and may have hampered its widespread
use in daily clinical practice. However, the radiation dose can be
decreased significantly when dedicated dose reduction techniques
are implemented for SPECT25,26 and CCTA.13,27 In fact, the last 61
patients of the present study were scanned using prospective ECG
triggering, resulting in an average radiation dose of 1.8+0.6 mSv
for the CCTA. Combined with new SPECT protocols including
low-dose and stress-only MPI scanning,12,25 radiation dose optim-
ization allows to reach values below 5 mSv for hybrid SPECT/
CCTA scanning.28 These dose reductions may improve the clinical
value of hybrid imaging, as the balance of harms and benefits is
shifted to the favourable end allowing such combined non-invasive
assessment of CAD to gain importance. Finally, data for MPI and
CCTA were acquired on separate stand-alone scanners and
hybrid images obtained by software fusion whereby misalignment
could result in mismatch. The fact that despite potential misalign-
ment matched findings allowed good risk stratification further
strengthens our results. In addition, the accuracy of the fusion soft-
ware and its clinical validity has been previously validated.5,6
Conclusions
This is the first study to show the independent prognostic value of
cardiac hybrid imaging findings. The unique advantage of cardiac
hybrid imaging is the complete non-invasive assessment of ana-
tomic and functional data. By revealing both coronary stenosis
and its functional relevance, the hybrid approach can provide com-
prehensive information to guide management decisions in CAD
patients. This, however, requires further validation in multicentre
studies. In addition to being intuitively convincing and to providing
incremental diagnostic information on functionally relevant coron-
ary stenosis,6 the present study documents that cardiac hybrid
imaging integrating SPECT with CCTA allows improved risk
stratification.
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